Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation

Autor: Akrivi, Chrysanthopoulou, Konstantinos, Kambas, Dimitrios, Stakos, Ioannis, Mitroulis, Alexandros, Mitsios, Veroniki, Vidali, Iliana, Angelidou, Magdalena, Bochenek, Stella, Arelaki, Athanasios, Arampatzioglou, Ioanna-Evdokia, Galani, Panagiotis, Skendros, Elias A, Couladouros, Stavros, Konstantinides, Evangelos, Andreakos, Katrin, Schäfer, Konstantinos, Ritis
Rok vydání: 2016
Předmět:
Zdroj: The Journal of pathology. 243(1)
ISSN: 1096-9896
Popis: Neutrophils and neutrophil-released meshwork structures termed neutrophil extracellular traps (NETs) are major mediators of thromboinflammation and emerging targets for therapy, yet the mechanisms and pathways that control the role of neutrophils in thromboinflammation remain poorly understood. Here, we explored the role of IFN-λ1/IL-29, a major antiviral cytokine recently shown to suppress the neutrophil migratory capacity, in prothrombotic and proNETotic functions of neutrophils. In an ex vivo human experimental setting of acute ST-segment elevation myocardial infarction (STEMI), we show that IFN-λ1/IL-29 hinders NET release and diminishes the amount of cytoplasmic TF in neutrophils. Since platelet-neutrophil interaction plays a major role in NET-induced thromboinflammation, we further studied how IFN-λ1/IL-29 may interrupt this interaction. In this context, we identified inorganic polyphosphate (polyP) as a platelet-derived NET inducer in STEMI. In arterial STEMI thrombi, polyP was present in platelets and in close proximity to NET remnants. PolyP release from activated platelets was dependent on thrombin present in infarcted artery plasma, resulting in NET formation by promoting mTOR inhibition and autophagy induction. The effect of polyP on mTOR inhibition was counteracted by IFN-λ1/IL-29 treatment, leading to inhibition of NET formation. Consistently, we show in an in vivo model of FeCl
Databáze: OpenAIRE
Externí odkaz: